Tyra Biosciences (TYRA) Net Cash Flow (2020 - 2026)
Tyra Biosciences (TYRA) posted Net Cash Flow of $7.6 million for Q1 2026, down 50.97% on a QoQ basis from $15.4 million in Q4 2025, and down 13.56% year-over-year from $8.8 million in Q1 2025.
Tyra Biosciences (TYRA) Net Cash Flow (2020 - 2026) Analysis & Trends
Tyra Biosciences' Net Cash Flow history runs 7 years deep, the most recent figure standing at $7.6 million for Q1 2026.
- Quarterly Net Cash Flow fell 13.56% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.8 million (up 89.74% YoY) and the FY2025 annual result came in at -$14.6 million, down 142.93% from the prior year.
- Net Cash Flow was $7.6 million for Q1 2026 at Tyra Biosciences, down from $15.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $196.4 million in Q1 2024 and bottomed at -$157.6 million in Q4 2023.
- A 5-year average of -$12.7 million and a median of -$9.5 million in 2023 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 2164.34% in 2024, while the deepest fall reached 1567.48% in 2024.
- Tyra Biosciences' Net Cash Flow stood at -$12.0 million in 2022, then slumped by 1213.94% to -$157.6 million in 2023, then jumped by 92.43% to -$11.9 million in 2024, then jumped by 229.43% to $15.4 million in 2025, then slumped by 50.97% to $7.6 million in 2026.
- Business Quant data shows TYRA's Net Cash Flow at $7.6 million in Q1 2026, $15.4 million in Q4 2025, and -$36.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.57 Mn |
| Mar 31, 2026 | 7.57 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Sep 30, 2025 | -36.54 Mn |
| Sep 30, 2025 | -36.54 Mn |
| Jun 30, 2025 | -2.23 Mn |
| Jun 30, 2025 | -2.23 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Dec 31, 2024 | -11.93 Mn |
| Dec 31, 2024 | -11.93 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Jun 30, 2024 | -154.88 Mn |
| Jun 30, 2024 | -154.88 Mn |
| Mar 31, 2024 | 196.36 Mn |
| Mar 31, 2024 | 196.36 Mn |
| Dec 31, 2023 | -157.65 Mn |
| Dec 31, 2023 | -157.65 Mn |